Past Event Schedule
DAY 1
DAY 1
Tuesday, 29 April 2025
8:45
ICBC BERLIN B2B 2025 OPENING REMARKS

ALEX ROGERS
CEO & EXECUTIVE PRODUCER, ICBC

Ngaio Bealum
9:00
Why MSOs Are Looking to Invest in Germany and Europe
Charlie Bachtell has served as Cresco Labs’ [CSE:CL] Chief Executive Officer since February 2015 after co-founding the company in 2013. He was named one of Chicago’s most visionary and accomplished business leaders in the Chicago Titan 100 awards and received the Captains of the Industry Award from the American Trade Association for Cannabis Hemp. Through his leadership of Cresco Labs, the company has been recognized as a Best-Led American Company by Inc. magazine. Currently, Mr. Bachtell is the Chairman of the National Cannabis Roundtable and is an adjunct professor at Northwestern University’s Pritzker School of Law, teaching a course on legal and regulatory issues in the cannabis industry.
Charlie Bachtell has served as Cresco Labs’ [CSE:CL] Chief Executive Officer since February 2015 after co-founding the company in 2013….
He was named one of Chicago’s most visionary and accomplished business leaders in the Chicago Titan 100 awards and received the Captains of the Industry Award from the American Trade Association for Cannabis Hemp. Through his leadership of Cresco Labs, the company has been recognized as a Best-Led American Company by Inc. magazine. Currently, Mr. Bachtell is the Chairman of the National Cannabis Roundtable and is an adjunct professor at Northwestern University’s Pritzker School of Law, teaching a course on legal and regulatory issues in the cannabis industry.

Charlie Bachtell
CEO and Founder of Cresco Labs
9:15
Germany’s New Government

Peter Homberg
9:45
Medical Cannabis In Germany

Alex Revich
CANADIAN MEDICAL CANNABIS PIONEER
MODERATOR

Matthias Fischer
FOUNDER AND MANAGING DIRECTOR, CANYMED; CCO GRÜNHORN

Benedikt Sons
CO-FOUNDER AND CEO, CANSATIVA GROUP

Dr. rer. nat. Adrian Fischer
PHYSICIAN AND NATURAL SCIENTIST, CO-FOUNDER & MANAGING DIRECTOR, DEMECAN

Torsten Greif
CEO, FOUR 20 PHARMA
10:25
Germany’s Evolving Cannabis Industry

Dirk Heitepriem
PRESIDENT & CHAIRMAN, GERMAN CANNABIS INDUSTRY ASSOCIATION (BvCW)
MODERATOR

Lisa Haag

Henry Wieker
BOARD MEMBER, BvCW; COORDINATOR, BCAv

Sita Schubert
EUMCA GENERAL SECRETARY

Marijn Roersch van der Hoogte
CO-FOUNDER OF HEMP-IMPACT.COM; CO-FOUNDER & VP, GERMAN CANNABIS INDUSTRY ASSOCIATION (BVCW)
11:05
European Cannabis Pilot Projects

Kai-Friedrich Niermann

Finn A. Hänsel
MANAGING DIRECTOR & A FOUNDER OF SANITY GROUP

Paul-Lukas Good
PRESIDENT, SWISS CANNABIS RESEARCH ASSOCIATION

Daniel S. Hübner
SENIOR SCIENCE MANAGER, CANNABIS RESEARCH LAB HUMBOLDT-UNIVERSITÄT ZU BERLIN

Deepak Anand
11:45
Global Cannabis Industry Horizons
Significant regulatory developments in Europe, explosive growth in key global markets, and recent M&A/investment transactions are fueling increased investor interest in global cannabis. As investors enter/re-enter the space, their expectations are increasingly more sophisticated, and competition for investment capital remains intense. In this dynamic session, cannabis businesses/start-ups and investors will gain key insights from expert panelists to help them align with emerging global market opportunities.
Significant regulatory developments in Europe, explosive growth in key global markets, and recent M&A/investment transactions are fueling increased investor interest in global cannabis..
As investors enter/re-enter the space, their expectations are increasingly more sophisticated, and competition for investment capital remains intense. In this dynamic session, cannabis businesses/start-ups and investors will gain key insights from expert panelists to help them align with emerging global market opportunities.

Jamie Pearson
INTERNATIONAL CONSULTANT, NEW HOLLAND GROUP

George Bellow
CO-FOUNDER, SOMAÍ PHARMACEUTICALS

David Hyde
FOUNDER & CEO, HYDE ADVISORY & INVESTMENTS INC

Margaret Brodie
CEO, RUBICON ORGANICS

Will Muecke

Raj Grover
FOUNDER, PRESIDENT & CEO, HIGH TIDE, INC
12:25
Break
13:20
Advanced Cultivation Technologies

Quinn Shiskin
PRESIDENT, MCINTYRE CREEK CANNABIS INC. (MCCI)
MODERATOR

Albert Eppinga

Franz Josef Sima

Rui Soares

Max Majot

Mikhail Sagal
14:00
Exploring The Latest Trends And Innovations In Cannabis Logistics

Yoram Eshel
14:30
German Cannabis Industry Update

Beau Whitney
15:00
Establishing International Brands

Ricardo Baca
FOUNDER & CEO, GRASSLANDS
MODERATOR

Jürgen Bickel
MANAGING DIRECTOR AND CO-FOUNDER, STORZ & BICKEL

Nick Avé
GENERAL MANAGER, ZAMNESIA

Lance Lambert

Barry Laxer
15:40
High Standards

Benjamin Patock
INTERNATIONAL RELATIONS, BOVEDA
MODERATOR

Jonathan Havens
MANAGING PARTNER BALTIMORE OFFICE AND CO-CHAIR OF BOTH THE CANNABIS LAW PRACTICE AND THE FOOD, BEVERAGE & AGRIBUSINESS PRACTICE; SAUL EWING LLP

Götz Schneider-Rothhaar

Atiyyah Ferouz
FOUNDER & CEO, AG CANN

Sebastien Beguerie
FOUNDER: ALPHA-CAT; KANAVAPE; GOLDEN BUDS

Frederik Bockslaff
FOUNDER & PARTNER, NIMROD RECHTSANWÄLTE
16:20
Bridging Disciplines
Cannabis research is a rapidly evolving field that touches on agronomy, biochemistry, pharmacology, materials science, and healthcare. This panel brings together a diverse group of experts, including plant scientists, biochemists, R&D leaders from the private sector, and science communicators, to explore how interdisciplinary collaboration can drive innovation and ensure scientific integrity. Drawing from hands-on experience in crop science, cannabinoid research, product development, medical practice, and international policy, the panelists will discuss how to advance cannabis research within the boundaries of international conventions. Topics covered during this panel will include sustainable cultivation practices, the biochemical complexity of the cannabis plant, translational research for consumer and medical use, and the role of education and public engagement. By bridging disciplines, the session will demonstrate how cannabis research can lead to real-world applications, support the development of research-based businesses, and contribute to improved public health at a global level.
Cannabis research is a rapidly evolving field that touches on agronomy, biochemistry, pharmacology, materials science, and healthcare.…
This panel brings together a diverse group of experts, including plant scientists, biochemists, R&D leaders from the private sector, and science communicators, to explore how interdisciplinary collaboration can drive innovation and ensure scientific integrity. Drawing from hands-on experience in crop science, cannabinoid research, product development, medical practice, and international policy, the panelists will discuss how to advance cannabis research within the boundaries of international conventions. Topics covered during this panel will include sustainable cultivation practices, the biochemical complexity of the cannabis plant, translational research for consumer and medical use, and the role of education and public engagement. By bridging disciplines, the session will demonstrate how cannabis research can lead to real-world applications, support the development of research-based businesses, and contribute to improved public health at a global level.

Lukáš Hurt
CEO, GREEN PUBLISHING
MODERATOR

Prof. Dr. Tamara Lah Turnšek

TJ Martin
VICE PRESIDENT OF RESEARCH & DEVELOPMENT, ABSTRAX

Andy Mannsfeld, MD

Prof. Dr. Simone Graeff-Hönninger
CHAIR OF AGRONOMY, INSTITUTE OF CROP SCIENCE, UNIVERSITY OF HOHENHEIM

Božidar Radišic
PROJECT MANAGER AND FOUNDER, RESEARCH NATURE INSTITUTE
17:00
The Evolving Industrial Hemp Industry

Johnny Green
MEDIA & CONTENT DIRECTOR, ICBC
MODERATOR

Morris Beegle
PRESIDENT, WE ARE FOR BETTER ALTERNATIVES (WAFBA)

Robert T. Hoban
MEMBER, CO-CHAIR OF THE CANNABIS INDUSTRY GROUP, & MEMBER-IN-CHARGE OF THE CLARK HILL DENVER OFFICE

Daniel Kruse

Chris Day
DAY 2
DAY 2
Wednesday, 30 April 2025
9:30
Safe Access To Medical Cannabis In Germany
Dr. Can Ansay, a notable figure in Germany’s medical cannabis sector and founder of the popular telemedicine platform, DrAnsay.com, will present his perspective on the significant growth of Germany’s medical cannabis industry following the removal of cannabis from the Narcotics List in April 2024. That change resulted in easier patient access, which Dr. Ansay’s platform monetized. Dr. Ansay’s approach expanded patient access to prescriptions, contributed to the exponential growth of Germany’s medical industry, and simultaneously attracted critical attention from a variety of German stakeholders, including competitors and journalists. While his platform strategy has sparked controversy, there have been zero negative consequences reported from increased access to medical cannabis, apart from the controversy itself. Buckle up – Dr. Ansay will take the audience on a ride of unique insights and predictions into the evolution and future of medical cannabis in Germany in a way that only he can.
Dr. Can Ansay, a notable figure in Germany’s medical cannabis sector and founder of the popular telemedicine platform, DrAnsay.com, will present his perspective on the significant growth of Germany’s medical cannabis industry...
following the removal of cannabis from the Narcotics List in April 2024. That change resulted in easier patient access, which Dr. Ansay’s platform monetized. Dr. Ansay’s approach expanded patient access to prescriptions, contributed to the exponential growth of Germany’s medical industry, and simultaneously attracted critical attention from a variety of German stakeholders, including competitors and journalists. While his platform strategy has sparked controversy, there have been zero negative consequences reported from increased access to medical cannabis, apart from the controversy itself. Buckle up – Dr. Ansay will take the audience on a ride of unique insights and predictions into the evolution and future of medical cannabis in Germany in a way that only he can

Dr. jur. Can Ansay
CEO, DR. ANSAY LTD.
9:45
Forming Strategic Partnerships

Sonny Moerenhout
MANAGING PARTNER, CULTIVATORS
MODERATOR

Michael Torrey

Scott Olin Schmidt

Narkis Tessler
CHIEF OF STRATEGY & BUSINESS DEVELOPMENT, MEDOCANN GROUP

Andrew Baukham

John Slaughter
FOUNDER & CEO, HIGH NORTH LABORATORIES
10:25
The High Cost of Compliance

Daniel Haymann
ATTORNEY AT LAW, MME LEGAL
MODERATOR

Ricardo Geada

John Fowler

Erin Butler

Sigfried Legeay
CFO & CO-FOUNDER, CANXCHANGE

Gašper Friškovec
CCO, THE TALMAN GROUP
11:05
Cannabis & Hemp Tourism as an Engine for Growth and Differentiation

Brian Applegarth
FOUNDING CHAIR, CANNABIS TRAVEL ASSOCIATION INTERNATIONAL (CTAI)
MODERATOR

Mara Gordon

Jim Zielinski

Cristina Sánchez

Ivan Ross Vrána
MANAGING PARTNER, DIPLOMAT CONSULTING

Teddy Cabugos
11:55
Cannabis Genetics

Bubba Nicholson
PROCUREMENT & MARKET SPECIALIST
MODERATOR

Alexandre Gauthier
VICE-PRESIDENT R&D, ORIGINE NATURE

Clinton Younge
FOUNDER, CHARLIE’S CANNABIS CO.

Dave Auger

Matthew Don-Carolis
VP OF SALES, SEGRA INTERNATIONAL
12:30
Break
13:30
Blazing Trails
Emerging regions like Africa, Asia, and Latin America are becoming key players in the cannabis industry. This panel will explore market entry strategies, local regulations, and the potential for growth. Panelists will also discuss the importance of creating and maintaining positive government relationships in emerging jurisdictions. Learn how businesses can navigate these markets while respecting cultural and regulatory nuances.
Emerging regions like Africa, Asia, and Latin America are becoming key players in the cannabis industry….
This panel will explore market entry strategies, local regulations, and the potential for growth. Panelists will also discuss the importance of creating and maintaining positive government relationships in emerging jurisdictions. Learn how businesses can navigate these markets while respecting cultural and regulatory nuances.

Adi Rozenfeld
PARTNER, HERZOG LAW
MODERATOR

Eidan Havas

Merlin MacDonald
DIRECTOR OF BUSINESS DEVELOPMENT, CARBON EXTRACTS

Natcha Klahan

Omar Khan
CHIEF COMMUNICATIONS & PUBLIC AFFAIRS OFFICER, HIGH TIDE, INC.
14:10
Breaking New Ground

Danielle Bernstein

Mary Szomjassy Brown
14:50
High Expectations
Cannabis consumer preferences are evolving rapidly around the world, from product types to ethical considerations. Consumption delivery methods are expanding and many consumers and patients are seeking products containing lesser-known cannabinoids beyond THC and CBD. Panelists will discuss the latest trends and how businesses can adapt to meet these demands, including how to incorporate AI technology for data collection and analysis. Gain insights into the future of cannabis consumption.
Cannabis consumer preferences are evolving rapidly around the world, from product types to ethical considerations….
Consumption delivery methods are expanding and many consumers and patients are seeking products containing lesser-known cannabinoids beyond THC and CBD. Panelists will discuss the latest trends and how businesses can adapt to meet these demands, including how to incorporate AI technology for data collection and analysis. Gain insights into the future of cannabis consumption.

Tim Powers
MODERATOR
FOUNDER, KIND SELECTIONS; CO-FOUNDER, CANNABIS TOLLING SOLUTIONS

Chris Sinacori

Tanner Stewart

Emily Fisher
CEO & FOUNDER, LEAFWELL

Lorenz Minks
15:30
Cannatech Catalysts

Alex Revich
CANADIAN MEDICAL CANNABIS PIONEER
MODERATOR

Eral Osmanoglou
CO-FOUNDER & HEAD OF R&D AT BECANEX GMBH

David Sandelman

Charlie Wang
CO-FOUNDER & CEO, CANNVITAL NV LLC

Peter Machalek
16:10
The Science Of Cannabis Extraction
The cannabis extraction sector of the emerging cannabis industry is currently undergoing significant changes from nearly every angle, including regulations, technology, and shifting consumer and patient demands. As the international cannabis import/export market continues to develop, products derived from cannabis extracts will be particularly popular, including solventless extract products and new products involving lesser-known cannabinoids. A panel of leading experts will discuss the current state of the international cannabis extraction sector and where the sector is headed in the coming years.
The cannabis extraction sector of the emerging cannabis industry is currently undergoing significant changes from nearly every angle,…
including regulations, technology, and shifting consumer and patient demands. As the international cannabis import/export market continues to develop, products derived from cannabis extracts will be particularly popular, including solventless extract products and new products involving lesser-known cannabinoids. A panel of leading experts will discuss the current state of the international cannabis extraction sector and where the sector is headed in the coming years.

Michael Knodt
FREELANCE JOURNALIST, AUTHOR OF CANNABIS-EXTRAKTION
MODERATOR

Nick Brousianos

Yogesh Jhamtani
CEO & CO-FOUNDER, BUFFALO EXTRACTION SYSTEMS

Serge Korovitsyn

Steve Fuhr
DIRECTOR OF SALES & BUSINESS DEVELOPMENT, SCIPHY SYSTEMS
16:50
The Science Behind GMP Compliance
The European Union’s Good Manufacturing Practices (GMP) standard helps ensure that cannabis products are safe for human consumption. All cannabis products produced domestically or imported to the European Union must be GMP-compliant before being sold in legal markets. Decontamination processes are at the heart of European GMP cannabis compliance. A team of expert panelists will discuss various approaches to cannabis decontamination, regulatory requirements, and the unique GMP compliance hurdles facing the emerging legal cannabis industry.
The European Union’s Good Manufacturing Practices (GMP) standard helps ensure that cannabis products are safe for human consumption….
All cannabis products produced domestically or imported to the European Union must be GMP-compliant before being sold in legal markets. Decontamination processes are at the heart of European GMP cannabis compliance. A team of expert panelists will discuss various approaches to cannabis decontamination, regulatory requirements, and the unique GMP compliance hurdles facing the emerging legal cannabis industry.

Atiyyah Ferouz
FOUNDER & CEO, AG CANN
MODERATOR

Brian Casey
CHIEF REVENUE OFFICER, VIST LABS; MANAGING PARTNER, BASM HOLDINGS

Joseph Edwards
CHIEF SCIENTIST AND VICE PRESIDENT, YOFUMO TECHNOLOGIES

Dr. David Surjo

George Terry

Arthur de Cordova
CEO & CO-FOUNDER, ZIEL
17:20
High On Packaging

Dean Arbit
CEO, bud.com & WAGNER DIMAS AG TECH
MODERATOR

Jesse Dixon

Lucas Jarzem

Luis Pilonieta

Cyrus Hambaz
FOUNDER & CEO, CANADIAN CLINICAL CANNABINOIDS